<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical management of pathologic nipple discharge</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical management of pathologic nipple discharge</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical management of pathologic nipple discharge</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Roshni Rao, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H15995129"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nipple discharge is the third most common breast-related complaint, after breast pain and breast mass. During their reproductive years, up to 80 percent of women will have an episode of nipple discharge [<a href="#rid1">1</a>], and 6.8 percent of women referred to a surgeon because of symptoms of a breast disorder have nipple discharge [<a href="#rid2">2</a>]. </p><p>Nipple discharge is categorized as normal milk production (lactation), physiologic nipple discharge (galactorrhea), or pathologic (suspicious) nipple discharge. The most common causes of pathologic nipple discharge are benign intraductal papilloma (35 to 48 percent), ductal ectasia (17 to 36 percent), and carcinoma (5 to 21 percent) [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/802.html" rel="external">"Nipple discharge"</a>.)</p><p>The surgical evaluation and management of pathologic nipple discharge is discussed here. The evaluation and treatment of physiologic nipple discharge is presented elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6638.html" rel="external">"Clinical manifestations and evaluation of hyperprolactinemia"</a> and  <a class="medical medical_review" href="/z/d/html/6630.html" rel="external">"Management of hyperprolactinemia"</a>.)</p><p class="headingAnchor" id="H37808970"><span class="h1">DEFINITION OF PATHOLOGIC NIPPLE DISCHARGE</span><span class="headingEndMark"> — </span>Pathologic nipple discharge, defined as secretory production of fluids other than milk due to pathological process in the breast, should be suspected by the presence of one or more of the following [<a href="#rid3">3,4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Unilateral nipple discharge </p><p class="bulletIndent1"><span class="glyph">●</span>Bloody nipple discharge</p><p class="bulletIndent1"><span class="glyph">●</span>Nipple discharge associated with a mass or skin changes</p><p></p><p>Grossly bloody or sanguineous nipple discharge simply means that a lesion in the duct is bleeding. The bleeding can be caused by an intraductal carcinoma (in situ or invasive), a bleeding papilloma, or benign fibrocystic changes with an active intraductal component (eg, plasma cell mastitis, ductal ectasia, intraductal hyperplasia, or papillomatosis). A meta-analysis of eight studies including 3110 patients showed that patients with bloody nipple discharge had a higher risk of breast cancer (52 percent) than patients with nonbloody nipple discharge (19 percent) [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/802.html" rel="external">"Nipple discharge", section on 'Pathologic (suspicious) nipple discharge'</a>.)</p><p class="bulletIndent1">Bilateral bloody nipple discharge is rare but has been reported in association with benign duct ectasia, papilloma, or carcinoma. It should be treated as pathologic discharge. </p><p></p><p class="headingAnchor" id="H10390676"><span class="h1">EVALUATION OF PATHOLOGIC NIPPLE DISCHARGE</span><span class="headingEndMark"> — </span>After clinical evaluation, all patients presenting with pathologic nipple discharge should undergo breast imaging to search for any underlying abnormality in the duct (or elsewhere in the breast) and direct surgical intervention  (<a class="graphic graphic_algorithm graphicRef104733" href="/z/d/graphic/104733.html" rel="external">algorithm 1</a>). </p><p class="headingAnchor" id="H3780511252"><span class="h2">Palpable breast mass</span><span class="headingEndMark"> — </span>Patients with pathologic nipple discharge who are found to have a concomitant palpable breast mass by clinical evaluation should undergo evaluation and treatment of the breast mass as described elsewhere. (See  <a class="medical medical_review" href="/z/d/html/808.html" rel="external">"Diagnostic evaluation of suspected breast cancer"</a>.)</p><p class="headingAnchor" id="H3670890152"><span class="h2">No palpable breast mass</span><span class="headingEndMark"> — </span>Patients presenting with pathologic nipple discharge but no palpable mass should first undergo either diagnostic mammography, focused breast ultrasonography, or both, depending on their age and sex [<a href="#rid6">6,7</a>]. Breast magnetic resonance imaging (MRI) usually follows if mammogram and ultrasound are negative. Suspicious lesions should undergo core needle biopsy with clip placement. (See  <a class="medical medical_review" href="/z/d/html/802.html" rel="external">"Nipple discharge", section on 'Pathologic discharge'</a>.)</p><p class="headingAnchor" id="H18667801"><span class="h1">TREATMENT OF PATHOLOGIC NIPPLE DISCHARGE</span><span class="headingEndMark"> — </span>Further treatment of pathologic nipple discharge depends upon the core needle biopsy result  (<a class="graphic graphic_algorithm graphicRef104733" href="/z/d/graphic/104733.html" rel="external">algorithm 1</a>):</p><p class="headingAnchor" id="H1610537240"><span class="h2">Breast cancer</span><span class="headingEndMark"> — </span>Biopsy findings of breast cancer (eg, invasive ductal cancer, papillary cancer, or ductal carcinoma in situ [DCIS]) mandate oncologic resection, which is described in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/737.html" rel="external">"Overview of the treatment of newly diagnosed, invasive, non-metastatic breast cancer", section on 'Early-stage breast cancer'</a>.)</p><p class="headingAnchor" id="H3755378943"><span class="h2">Benign lesions</span><span class="headingEndMark"> — </span>The surgical management of patients with pathologic nipple discharge associated with benign lesions is controversial.</p><p class="headingAnchor" id="H1344977674"><span class="h3">Treatment of lesions</span><span class="headingEndMark"> — </span>Removing a lesion is the same as performing a lumpectomy. (See  <a class="medical medical_review" href="/z/d/html/807.html" rel="external">"Breast-conserving therapy", section on 'Lumpectomy'</a>.)</p><p class="headingAnchor" id="H3656547744"><span class="h4">Benign lesions with high-risk features</span><span class="headingEndMark"> — </span>Biopsy findings of intraductal papillomas, atypical ductal hyperplasia, atypical lobular hyperplasia, and radial scar are benign but high-risk lesions. For these patients, the primary concerns are the known rates of carcinoma associated with these specific lesions found on core needle biopsy and the risk of sampling error that may occur with needle biopsy. Because there does not appear to be a group in which surgical excision can be omitted, we suggest that all benign lesions with high-risk features be surgically excised to rule out concomitant malignancy as well as to alleviate the nipple discharge. (See  <a class="medical medical_review" href="/z/d/html/743.html" rel="external">"Atypia and lobular carcinoma in situ: High-risk lesions of the breast"</a>.) </p><p class="headingAnchor" id="H3129800889"><span class="h4">Benign lesions without high-risk features</span><span class="headingEndMark"> — </span>Generally speaking, benign breast lesions without high-risk features, such as usual ductal hyperplasia and fibroadenoma, do not require surgical excision. It is controversial whether surgical excision is necessary for all intraductal papilloma diagnosed by core needle biopsy [<a href="#rid8">8-18</a>]. There is emerging literature that supports nonsurgical management of radiologic-pathologic concordant papillomas without atypia [<a href="#rid19">19-26</a>]. Currently, some UpToDate contributors excise all lesions associated with pathologic nipple discharge, while other UpToDate contributors do not excise lesions that are biopsy-proven to be benign without high-risk factors and concordant with imaging studies. </p><p>A prospective trial that will hopefully definitively answer this question has been initiated by the Breast Cancer Research Consortium (TBCRC 034) seeking to find the upgrade rate of adjacent invasive carcinoma and/or DCIS for patients diagnosed with intraductal papilloma without atypia. (See  <a class="medical medical_review" href="/z/d/html/806.html" rel="external">"Overview of benign breast diseases", section on 'Proliferative lesions without atypia'</a>.)</p><p class="headingAnchor" id="H809212602"><span class="h3">Treatment of the discharging duct</span><span class="headingEndMark"> — </span>The technique of terminal duct excision is described below. (See <a class="local">'Single-duct excision'</a> below.)</p><p>After core needle biopsy or surgical excision of the lesion, the nipple discharge often ceases, in which case some UpToDate contributors perform no further intervention. These contributors argue that pathologic nipple discharge is most often caused by lesions such as papilloma or duct ectasia, excision of which should stop the nipple discharge/bleeding, in which case a true duct excision would not be necessary. However, if the nipple discharge persists, the discharge duct should then be excised for symptomatic relief. </p><p>Other UpToDate contributors suggest that all discharging ducts associated with pathologic, especially bloody, discharge should be surgically excised with a terminal duct excision because there are no prospective data that support not excising the duct [<a href="#rid27">27,28</a>]. A directed terminal duct excision still leaves the vast majority of ducts in place.</p><p class="headingAnchor" id="H3543769547"><span class="h2">No identifiable lesion</span><span class="headingEndMark"> — </span>Patients who have pathologic nipple discharge but do not have any identifiable lesion on mammography, ultrasound, or magnetic resonance imaging (MRI) should undergo excision of the discharging duct(s) for symptomatic relief and to definitively exclude a lesion [<a href="#rid29">29</a>]. (See <a class="local">'Single-duct excision'</a> below.)</p><p class="headingAnchor" id="H15995173"><span class="h1">PREOPERATIVE PREPARATION</span></p><p class="headingAnchor" id="H15995203"><span class="h2">Surgical anatomy</span><span class="headingEndMark"> — </span>Breasts are located within the superficial fascia of the anterior chest wall, with the majority of the breast tissue resting on the pectoralis major fascia  (<a class="graphic graphic_figure graphicRef88523" href="/z/d/graphic/88523.html" rel="external">figure 1</a>) [<a href="#rid30">30</a>]. Breasts are primarily composed of fatty tissue and breast parenchyma. </p><p>Anatomical cross-sectional studies reveal 18 to 25 ducts behind the nipple, but lactational studies show only 8 to 12 ductal orifices that produce milk. Thus, many of the ducts are truncated without developing into formal lactiferous ducts with branching glands. These truncated ducts usually terminate around the areolar edge. The remaining larger ducts branch widely and into differing quadrants. </p><p>Most nipples contain five to nine ductal orifices arranged in a central and a peripheral group [<a href="#rid31">31</a>]. The central ducts have a branching pattern shaped like a tear drop located directly behind the nipple and course posteriorly toward the chest wall, while the peripheral ducts branch widely and cover large areas in a radial manner [<a href="#rid31">31</a>]. Three-dimensional reconstruction of the breast reveals that the typical breast contains 15 to 20 mammary ductal/lobular systems  (<a class="graphic graphic_picture graphicRef88526" href="/z/d/graphic/88526.html" rel="external">picture 1</a>) [<a href="#rid32">32</a>]. </p><p>The majority of intraductal lesions (especially papillomas) are in a subareolar position [<a href="#rid33">33</a>], although they can occur in a more peripheral location [<a href="#rid34">34</a>]. Careful dissection reveals that most ducts increase in diameter as they traverse deeper into the breast and that not all orifices are located within the very top section of the nipple [<a href="#rid35">35</a>]. A thorough understanding of ductal anatomy will assist surgeons in optimizing their surgical approaches.</p><p class="headingAnchor" id="H15995210"><span class="h2">Anesthesia considerations</span><span class="headingEndMark"> — </span>Performance of duct excision surgery under general anesthesia may be better for some patients due to the sensitivity of the nipple-areolar complex. Appropriate risk screening should be performed in patients prior to undergoing general anesthesia [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/z/d/html/4816.html" rel="external">"Preoperative medical evaluation of the healthy adult patient"</a>.)</p><p>For motivated patients, duct excision can be performed under local anesthesia with intravenous sedation. A nipple block is generally performed by infiltrating local anesthetic along the superior and inferior aspect of the nipple-areolar complex. This can be done initially superficially and then at deeper levels. Avoid infiltration directly at the nipple duct core to maintain the anatomy and visualization in this area. Typically, local anesthesia without <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> should be used to minimize the theoretical risk of necrosing small blood vessels near the nipple. </p><p class="headingAnchor" id="H10392713"><span class="h2">Localization</span><span class="headingEndMark"> — </span>If an intraductal lesion is not palpable or not clearly associated with nipple discharge, preoperative localization can be performed to facilitate excision. Localizing the target lesion ensures the surgeon can target the appropriate area of the breast for removal but has not been shown to decrease re-excision rate. It is particularly helpful for lesions that are not located in the immediate subareolar location. </p><p>Localization is typically performed with mammographic or ultrasound guidance. Commonly, localization is performed via placement of a thin wire into the lesion of concern [<a href="#rid37">37,38</a>]. Alternate methods of localization such as intraoperative ultrasound localization [<a href="#rid39">39,40</a>], hematoma-guided localization [<a href="#rid41">41,42</a>], seed localization [<a href="#rid43">43,44</a>], radiocolloid localization [<a href="#rid45">45</a>], and reflector-guided localization [<a href="#rid46">46</a>] have also become available. (See  <a class="medical medical_review" href="/z/d/html/116309.html" rel="external">"Techniques to reduce positive margins in breast-conserving surgery"</a>.)</p><p>Another approach is to perform preoperative galactography with instillation of a mixture of <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">methylene blue</a> and radiopaque dye, which can provide a visual image of the course of the duct as well as aid in intraoperative identification of the targeted duct, which will be filled with blue dye. This can help limit the dissection to the area of the intraductal lesion and increase the likelihood of identifying a lesion at pathology [<a href="#rid47">47</a>]. (See <a class="local">'Single-duct excision'</a> below.)</p><p class="headingAnchor" id="H10391440"><span class="h1">SURGICAL TECHNIQUES</span><span class="headingEndMark"> — </span>The breast surgeon may elect to excise a single duct or the entire ductal system, depending upon whether the pathologic nipple discharge can be traced to a single duct.</p><p>In either case, it is important to discuss with premenopausal women that any duct excision may preclude lactation in the future. Although some women can still breastfeed after a localized excision of a single duct, the scarring associated with healing can still make this difficult or impossible, and women should be counseled as to this possibility. Any duct excision can also change the sensitivity of the nipple, including hyposensitivity and hypersensitivity. </p><p class="headingAnchor" id="H3121556526"><span class="h2">Single-duct excision</span><span class="headingEndMark"> — </span>When a discharging duct can be identified with the assistance of a lacrimal duct probe, <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">methylene blue</a> injection, or another method, a single duct can be excised without injuring the other ductal elements. This is the preferred approach in patients who wish to preserve the ability to breastfeed and may preserve the ability of the nipple to respond to sexual stimulus [<a href="#rid48">48</a>]. </p><p>An intraductal papilloma can be resected over a lacrimal duct probe gently placed in the duct [<a href="#rid49">49</a>]. Alternatively, a nipple flap duct resection can be performed. In this procedure, the areolar skin is dissected back with a gentle teasing dissection to the subareolar region where the abnormal duct can be identified as larger and darker than the other lactiferous ducts. The ductal abnormality can be confirmed by gentle occlusion of the duct with a hemostat, which will demonstrate that the nipple secretion no longer flows. The duct is then resected by ligation of its cutaneous end followed by dissection and excision of the length of duct that appears abnormal and its intraluminal lesion.</p><p>The discharging duct can also be identified with the assistance of <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">methylene blue</a>  (<a class="graphic graphic_movie graphicRef103493" href="/z/d/graphic/103493.html" rel="external">movie 1</a>). One study utilized a light-emitting wire to enhance visualization of the involved duct and reported shorter surgery times with smaller amounts of tissue volume excised when this technique was compared with methylene blue injection [<a href="#rid50">50</a>]. Dissection is then carried out to completely remove the duct without injuring the other nipple ductal elements. If the location of the lesion is not known, care should be taken to remove 2 to 3 cm of breast parenchyma deep to the nipple itself, thereby maximizing the chances of excising the target lesion [<a href="#rid11">11,51,52</a>]. </p><p>It is important to orient the specimen to allow for directed excision of surgical margins if cancer is the final diagnosis. Additionally, a specimen radiograph should be obtained if localization was performed to ensure removal of the area of concern.</p><p class="headingAnchor" id="H15995226"><span class="h2">Complete subareolar duct excision</span><span class="headingEndMark"> — </span>Occasionally, a complete subareolar duct excision, also called complete terminal duct excision, is performed for intractable discharge from multiple ducts that is causing significant distress to the patient; copious amounts of nipple discharge may be anxiety provoking and socially embarrassing. </p><p>In these patients, surgery is intended to alleviate nipple discharge as a symptom and is appropriate even without pathologic findings (eg, intraductal mass). A period of observation with no nipple stimulation is recommended prior to complete subareolar duct excision, which alone sometimes will alleviate the nipple discharge. </p><p>For patients who require complete subareolar duct excision, a periareolar incision along the lateral portion of the areola that circumnavigates no more than 30 percent of the circumference of the areola allows adequate access and minimizes the risk of nipple necrosis  (<a class="graphic graphic_picture graphicRef103423" href="/z/d/graphic/103423.html" rel="external">picture 2</a>) [<a href="#rid53">53</a>]. Dissection is carried toward the nipple duct elements with a combination of electrocautery and blunt dissection. The ductal elements are freed from their attachments to the nipple with sharp dissection, taking care not to injure the nipple itself. This can be done by placing the operator's nondominant hand on the skin side of the nipple. </p><p>After complete subareolar ductal system excision, some surgeons advocate closure of the orifice stumps from the underside of the nipple with 4-0 Prolene sutures to avoid potential formation of fistulas [<a href="#rid51">51,53</a>]. There are no studies to confirm the efficacy of this type of suture closure to reduce fistulas as opposed to simply letting the subareolar tissue scar in with time.</p><p>Skin closure can be performed with standard suture closure or with tissue adhesives, with no data to support one approach over the other [<a href="#rid54">54</a>]. Suture closure is typically performed with two layers of sutures, a deep dermal layer followed by a subcuticular skin layer. Due to the small amount of tissue excised, there is no need for placement of surgical drains, and patients normally heal without difficulty [<a href="#rid27">27</a>].</p><p>All excised tissue should still be appropriately oriented and sent for pathologic analysis, even if there is no concern for malignancy. Excellent rates of success and symptom relief have been reported with this approach [<a href="#rid55">55,56</a>]. Nevertheless, given the absence of identified pathology, routine imaging follow-up is recommended for early detection of any residual pathologic lesions. </p><p class="headingAnchor" id="H15995254"><span class="h1">POSTOPERATIVE CARE</span><span class="headingEndMark"> — </span>Most standard duct excisions are performed as an outpatient procedure. Narcotic pain medications are prescribed for patients to take as needed. If a waterproof dressing such as Tegaderm is applied, the patient may shower while the primary dressing is maintained. The primary dressing is usually removed 48 to 72 hours after the operation. </p><p>All specimens removed are sent for pathological analysis. Further follow-up is dependent upon the specific pathology. (See  <a class="medical medical_review" href="/z/d/html/15781.html" rel="external">"Approach to the patient following treatment for breast cancer"</a>.)</p><p class="headingAnchor" id="H15995268"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications such as infection, nipple necrosis, duct fistula, and hematoma have been reported [<a href="#rid10">10,27,48</a>], with the risk of any of these complications being less than 5 percent. </p><p>It is critical to remove the ductal tissue without causing injury to the nipple, and surgeons need to be continuously cognizant of the proximity of the blade to the nipple skin. Despite that, nipple necrosis or duct fistulas may form after subareolar duct excision [<a href="#rid53">53</a>], and additional operations may be required.</p><p>Although rare, and typically associated with subcutaneous injection, complications with <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">methylene blue</a> have been reported [<a href="#rid57">57</a>]. The surgical and anesthesia teams should be aware of this; complications, such as allergic reaction, need to be managed appropriately. </p><p class="headingAnchor" id="H3626567504"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/119871.html" rel="external">"Society guideline links: Breast surgery"</a>.)</p><p class="headingAnchor" id="H1196214"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Nonlactating nipple discharge can be physiologic or pathologic. Physiologic nipple discharge is treated medically. Pathologic nipple discharge requires further evaluation and surgical treatment. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/z/d/html/802.html" rel="external">"Nipple discharge"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pathologic nipple discharge is defined as nipple discharge that is unilateral, bloody, or associated with a mass or skin lesions. (See <a class="local">'Definition of pathologic nipple discharge'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After clinical evaluation, all patients presenting with pathologic nipple discharge should undergo breast imaging, usually followed by core needle biopsy to search for any underlying abnormality in the duct (or elsewhere in the breast) and direct surgical intervention  (<a class="graphic graphic_algorithm graphicRef104733" href="/z/d/graphic/104733.html" rel="external">algorithm 1</a>). This is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/802.html" rel="external">"Nipple discharge", section on 'Pathologic discharge'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most nonlactating women and men with pathologic nipple discharge require surgical treatment, the extent of which is guided by biopsy results  (<a class="graphic graphic_algorithm graphicRef104733" href="/z/d/graphic/104733.html" rel="external">algorithm 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with biopsy findings of invasive or in situ cancer should undergo appropriate oncologic treatment. (See  <a class="medical medical_review" href="/z/d/html/737.html" rel="external">"Overview of the treatment of newly diagnosed, invasive, non-metastatic breast cancer", section on 'Early-stage breast cancer'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with biopsy findings of benign lesions with high-risk features (eg, papilloma with atypia), we suggest surgical excision of the lesion (ie, lumpectomy) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The decision to excise benign lesions without high-risk features associated with pathologic nipple discharge (eg, papilloma without atypia) is controversial, and there is a lack of consensus. Some UpToDate contributors excise benign lesions without high-risk features, while others do not. (See <a class="local">'Treatment of lesions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In addition, there is also lack of consensus as to whether or not the discharging duct(s) associated with the lesions should also be excised. Some UpToDate contributors routinely excise all discharging ducts associated with pathologic discharge, while others only excise the duct if the nipple discharge persists after biopsy or excision of the lesion. (See <a class="local">'Treatment of the discharging duct'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients without identifiable lesions on imaging studies require excision of the discharging duct for symptomatic relief and to definitively exclude a lesion. (See <a class="local">'No palpable breast mass'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Perioperative localization of the discharging duct allows for excision of a single duct. Alternatively, complete subareolar duct excision is performed for symptomatic patients in whom nipple discharge cannot be localized. (See <a class="local">'Surgical techniques'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Expert Panel on Breast Imaging, Sanford MF, Slanetz PJ, et al. ACR Appropriateness Criteria® Evaluation of Nipple Discharge: 2022 Update. J Am Coll Radiol 2022; 19:S304.</a></li><li><a class="nounderline abstract_t">Santen RJ, Mansel R. Benign breast disorders. N Engl J Med 2005; 353:275.</a></li><li><a class="nounderline abstract_t">Hussain AN, Policarpio C, Vincent MT. Evaluating nipple discharge. Obstet Gynecol Surv 2006; 61:278.</a></li><li><a class="nounderline abstract_t">Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am 2013; 40:459.</a></li><li><a class="nounderline abstract_t">Chen L, Zhou WB, Zhao Y, et al. Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2012; 132:9.</a></li><li><a class="nounderline abstract_t">Gray RJ, Pockaj BA, Karstaedt PJ. Navigating murky waters: a modern treatment algorithm for nipple discharge. Am J Surg 2007; 194:850.</a></li><li><a class="nounderline abstract_t">Bahl M, Baker JA, Greenup RA, Ghate SV. Diagnostic Value of Ultrasound in Female Patients With Nipple Discharge. AJR Am J Roentgenol 2015; 205:203.</a></li><li><a class="nounderline abstract_t">El-Sayed ME, Rakha EA, Reed J, et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Histopathology 2008; 53:650.</a></li><li><a class="nounderline abstract_t">Chang JM, Cho N, Moon WK, et al. Does ultrasound-guided directional vacuum-assisted removal help eliminate abnormal nipple discharge in patients with benign intraductal single mass? Korean J Radiol 2009; 10:575.</a></li><li><a class="nounderline abstract_t">Jaffer S, Nagi C, Bleiweiss IJ. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. Cancer 2009; 115:2837.</a></li><li><a class="nounderline abstract_t">Ahmadiyeh N, Stoleru MA, Raza S, et al. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol 2009; 16:2264.</a></li><li><a class="nounderline abstract_t">Maxwell AJ. Ultrasound-guided vacuum-assisted excision of breast papillomas: review of 6-years experience. Clin Radiol 2009; 64:801.</a></li><li><a class="nounderline abstract_t">Wei H, Jiayi F, Qinping Z, et al. Ultrasound-guided vacuum-assisted breast biopsy system for diagnosis and minimally invasive excision of intraductal papilloma without nipple discharge. World J Surg 2009; 33:2579.</a></li><li><a class="nounderline abstract_t">Jackman RJ, Nowels KW, Shepard MJ, et al. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994; 193:91.</a></li><li><a class="nounderline abstract_t">Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 2000; 175:1341.</a></li><li><a class="nounderline abstract_t">Brem RF, Behrndt VS, Sanow L, Gatewood OM. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 1999; 172:1405.</a></li><li><a class="nounderline abstract_t">Hayes BD, O'Doherty A, Quinn CM. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol 2009; 62:1136.</a></li><li><a class="nounderline abstract_t">Dillon MF, McDermott EW, Hill AD, et al. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy. Ann Surg Oncol 2007; 14:704.</a></li><li><a class="nounderline abstract_t">Woods ER, Helvie MA, Ikeda DM, et al. Solitary breast papilloma: comparison of mammographic, galactographic, and pathologic findings. AJR Am J Roentgenol 1992; 159:487.</a></li><li><a class="nounderline abstract_t">Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 2006; 30:665.</a></li><li><a class="nounderline abstract_t">Valdes EK, Feldman SM, Boolbol SK. Papillary lesions: a review of the literature. Ann Surg Oncol 2007; 14:1009.</a></li><li><a class="nounderline abstract_t">Mercado CL, Hamele-Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006; 238:801.</a></li><li><a class="nounderline abstract_t">Sydnor MK, Wilson JD, Hijaz TA, et al. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007; 242:58.</a></li><li><a class="nounderline abstract_t">Ciatto S, Andreoli C, Cirillo A, et al. The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases. Tumori 1991; 77:41.</a></li><li><a class="nounderline abstract_t">Nakhlis F, Ahmadiyeh N, Lester S, et al. Papilloma on core biopsy: excision vs. observation. Ann Surg Oncol 2015; 22:1479.</a></li><li><a class="nounderline abstract_t">Genco IS, Tugertimur B, Manolas PA, et al. Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study. Am J Surg 2020; 220:677.</a></li><li><a class="nounderline abstract_t">Morrogh M, Park A, Elkin EB, King TA. Lessons learned from 416 cases of nipple discharge of the breast. Am J Surg 2010; 200:73.</a></li><li><a class="nounderline abstract_t">Montroni I, Santini D, Zucchini G, et al. Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision. Breast Cancer Res Treat 2010; 123:895.</a></li><li><a class="nounderline abstract_t">Alcock C, Layer GT. Predicting occult malignancy in nipple discharge. ANZ J Surg 2010; 80:646.</a></li><li><a class="nounderline abstract_t">Reynolds A. Stereotactic breast biopsy: a review. Radiol Technol 2009; 80:447M.</a></li><li><a class="nounderline abstract_t">Love SM, Barsky SH. Anatomy of the nipple and breast ducts revisited. Cancer 2004; 101:1947.</a></li><li><a class="nounderline abstract_t">Ohtake T, Kimijima I, Fukushima T, et al. Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer 2001; 91:2263.</a></li><li><a class="nounderline abstract_t">Brookes MJ, Bourke AG. Radiological appearances of papillary breast lesions. Clin Radiol 2008; 63:1265.</a></li><li><a class="nounderline abstract_t">Ganesan S, Karthik G, Joshi M, Damodaran V. Ultrasound spectrum in intraductal papillary neoplasms of breast. Br J Radiol 2006; 79:843.</a></li><li><a class="nounderline abstract_t">Rusby JE, Brachtel EF, Michaelson JS, et al. Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications. Breast Cancer Res Treat 2007; 106:171.</a></li><li><a class="nounderline abstract_t">Williams FM, Bergin JD. Cardiac screening before noncardiac surgery. Surg Clin North Am 2009; 89:747.</a></li><li><a class="nounderline abstract_t">Siemssen OJ, Blichert-Toft M, Pedersen ML, et al. Mammography directed wire marking of nonpalpable breast lesions. A consecutive biopsy study of 100 patients. Acta Chir Scand 1981; 147:525.</a></li><li><a class="nounderline abstract_t">Jensen SR, Luttenegger TJ. Wire localization of nonpalpable breast lesions. Radiology 1979; 132:484.</a></li><li><a class="nounderline abstract_t">Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg 2003; 186:378.</a></li><li><a class="nounderline abstract_t">Rahusen FD, Bremers AJ, Fabry HF, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 2002; 9:994.</a></li><li><a class="nounderline abstract_t">Thompson M, Henry-Tillman R, Margulies A, et al. Hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol 2007; 14:148.</a></li><li><a class="nounderline abstract_t">Smith LF, Henry-Tillman R, Harms S, et al. Hematoma-directed ultrasound-guided breast biopsy. Ann Surg 2001; 233:669.</a></li><li><a class="nounderline abstract_t">Rao R, Moldrem A, Sarode V, et al. Experience with seed localization for nonpalpable breast lesions in a public health care system. Ann Surg Oncol 2010; 17:3241.</a></li><li><a class="nounderline abstract_t">Hughes JH, Mason MC, Gray RJ, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J 2008; 14:153.</a></li><li><a class="nounderline abstract_t">Lavoué V, Nos C, Clough KB, et al. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol 2008; 15:2556.</a></li><li><a class="nounderline abstract_t">Mango VL, Wynn RT, Feldman S, et al. Beyond Wires and Seeds: Reflector-guided Breast Lesion Localization and Excision. Radiology 2017; 284:365.</a></li><li><a class="nounderline abstract_t">Cabioglu N, Hunt KK, Singletary SE, et al. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg 2003; 196:354.</a></li><li><a class="nounderline abstract_t">Sakorafas GH. Nipple discharge: current diagnostic and therapeutic approaches. Cancer Treat Rev 2001; 27:275.</a></li><li><a class="nounderline abstract_t">Dennis MA, Parker S, Kaske TI, et al. Incidental treatment of nipple discharge caused by benign intraductal papilloma through diagnostic Mammotome biopsy. AJR Am J Roentgenol 2000; 174:1263.</a></li><li><a class="nounderline abstract_t">Ma XP, Wang W, Kong Y, et al. A Novel Light-Emitting Wire Enhances the Marking and Visualization of Pathologic Mammary Ducts During Selective Microdochectomy. Ann Surg Oncol 2016; 23:796.</a></li><li><a class="nounderline abstract_t">Hadfield GJ. Further experience of the operation for excision of the major duct system of the breast. Br J Surg 1968; 55:530.</a></li><li><a class="nounderline abstract_t">HADFIELD J. Excision of the major duct system for benign disease of the breast. Br J Surg 1960; 47:472.</a></li><li><a class="nounderline abstract_t">Srivastava A, Griwan MS, Samaiyar SS, Sharma LK. A safe technique of major mammary duct excision. J R Coll Surg Edinb 1995; 40:35.</a></li><li><a class="nounderline abstract_t">Farion K, Osmond MH, Hartling L, et al. Tissue adhesives for traumatic lacerations in children and adults. Cochrane Database Syst Rev 2002; :CD003326.</a></li><li><a class="nounderline abstract_t">Lanitis S, Filippakis G, Thomas J, et al. Microdochectomy for single-duct pathologic nipple discharge and normal or benign imaging and cytology. Breast 2008; 17:309.</a></li><li><a class="nounderline abstract_t">Wong L, Chung YF, Wong CY. Microdochectomy for single-duct nipple discharge. Ann Acad Med Singapore 2000; 29:198.</a></li><li><a class="nounderline abstract_t">Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005; 189:236.</a></li></ol></div><div id="topicVersionRevision">Topic 14983 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36436958" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : ACR Appropriateness Criteria®Evaluation of Nipple Discharge: 2022 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034013" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Benign breast disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16551379" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Evaluating nipple discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24021252" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Benign breast disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21947751" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18005783" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Navigating murky waters: a modern treatment algorithm for nipple discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26102400" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Diagnostic Value of Ultrasound in Female Patients With Nipple Discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19076681" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19885313" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Does ultrasound-guided directional vacuum-assisted removal help eliminate abnormal nipple discharge in patients with benign intraductal single mass?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19402174" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19484312" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19589419" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Ultrasound-guided vacuum-assisted excision of breast papillomas: review of 6-years experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19777298" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Ultrasound-guided vacuum-assisted breast biopsy system for diagnosis and minimally invasive excision of intraductal papilloma without nipple discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8090927" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11044038" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10227526" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19946101" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17151788" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1503011" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Solitary breast papilloma: comparison of mammographic, galactographic, and pathologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16723843" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17206486" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Papillary lesions: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16424237" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Papillary lesions of the breast at percutaneous core-needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17090707" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2017798" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25361885" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Papilloma on core biopsy: excision vs. observation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32007236" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20079481" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Lessons learned from 416 cases of nipple discharge of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20354781" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20840410" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Predicting occult malignancy in nipple discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19457848" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Stereotactic breast biopsy: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15382093" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Anatomy of the nipple and breast ducts revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11413514" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18929044" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Radiological appearances of papillary breast lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16641415" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ultrasound spectrum in intraductal papillary neoplasms of breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17221150" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19782835" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cardiac screening before noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7345843" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Mammography directed wire marking of nonpalpable breast lesions. A consecutive biopsy study of 100 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/461814" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Wire localization of nonpalpable breast lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14553854" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464592" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17058127" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Hematoma-directed ultrasound-guided (HUG) breast lumpectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11323506" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hematoma-directed ultrasound-guided breast biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20535570" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Experience with seed localization for nonpalpable breast lesions in a public health care system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18248562" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : A multi-site validation trial of radioactive seed localization as an alternative to wire localization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18574635" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28430555" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Beyond Wires and Seeds: Reflector-guided Breast Lesion Localization and Excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12648684" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11871863" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Nipple discharge: current diagnostic and therapeutic approaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10789774" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Incidental treatment of nipple discharge caused by benign intraductal papilloma through diagnostic Mammotome biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26511262" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A Novel Light-Emitting Wire Enhances the Marking and Visualization of Pathologic Mammary Ducts During Selective Microdochectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5663437" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Further experience of the operation for excision of the major duct system of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13830762" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Excision of the major duct system for benign disease of the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7738895" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A safe technique of major mammary duct excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12137689" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Tissue adhesives for traumatic lacerations in children and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18207405" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Microdochectomy for single-duct pathologic nipple discharge and normal or benign imaging and cytology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10895339" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Microdochectomy for single-duct nipple discharge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15720998" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
